@neuroblastomaaustralia

Neuroblastoma Australia funds clinical trials and laboratory research focused on treating neuroblastoma, a high-risk cancer primarily affecting children under five years old. The organization coordinates with medical research institutions across Australia to advance therapeutic developments and improve patient outcomes. Their research funding initiatives target early-stage investigations and translational studies aimed at bringing new treatment options to pediatric oncology centers. The foundation's signature fundraising program, Trek2Cure, guides participants through a five-day hiking expedition on the Larapinta Trail in Central Australia's MacDonnell Ranges. Run2Cure events activate community support through organized fun runs in Brisbane and other Australian cities. Cook2Cure gatherings pair donors with notable Australian chefs for curated dining experiences supporting the foundation's research mission. Neuroblastoma Australia maintains partnerships with pediatric cancer research centers, medical institutions, and community organizations across the country. The foundation channels donations directly into laboratory studies and clinical trials investigating new therapeutic approaches. Their funding supports Australian researchers working to develop targeted treatments for children diagnosed with neuroblastoma.